Spironolactone Tablet
Product Images NDC 42708-126

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 42708-126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

42708 126 30

Label for Spironolactone Tablets USP 25 mg, oral tablets, 30 count, distributed by QPharma, Inc. The label includes sample status, storage instructions to keep at controlled room temperature, and placeholders for dosage instructions. It also states 'Rx Only' and advises keeping the container tightly closed and out of reach of children.*

FDA Label Image

20 (Spironolactone Tablets Usp 1)

Chemical structure of spironolactone depicting its steroidal backbone with lactone and thioester functional groups. The diagram illustrates the molecular framework of the active ingredient spironolactone found in the oral tablet dosage form.*

FDA Label Image

10 (Spironolactone Tablets Usp 2)

A line graph showing probability over months for two groups: Spironolactone (n=822) and Placebo (n=841). The vertical axis represents probability from 0 to 1, and the horizontal axis shows time in months from 0 to 48. The Spironolactone group has a higher probability trend than Placebo, with a log-rank p-value of less than 0.001 indicated.*

FDA Label Image

10 (Spironolactone Tablets Usp 3)

A forest plot chart showing subgroup analysis with hazard ratios (HR) and 95% confidence intervals (CI) for various patient groups related to Spironolactone. Subgroups include age, sex, race, LVEF percentage, heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, and use of digoxin, ACE inhibitors, or beta blockers. The horizontal axis represents HR values where lower values favor Spironolactone and higher values favor placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.